Preferred Label : Bortezomib/Rituximab Regimen;
NCIt synonyms : Bortezomib/Rituximab; Bortezomib-Rituximab; Bortezomib-Rituximab Regimen; Rituximab-Bortezomib; Bortezomib Plus Rituximab; Rituximab/Bortezomib; Velcade/Rituxan;
NCIt related terms : Bortezomib and Rituximab (VR); Bortezomib and Rituximab-arrx (VR); Bortezomib and Rituximab-pvvr (VR); Bortezomib and Rituximab-rixa (VR); Bortezomib and Rituximab-blit (VR); Bortezomib and Rituximab-rite (VR); Bortezomib and Rituximab-abbs (VR); Bortezomib and Rituximab-rixi (VR);
NCIt definition : A regimen consisting of bortezomib and rituximab that may be used for the treatment
of some forms of non-Hodgkin's lymphoma (NHL), such as follicular lymphoma, mantle
cell lymphoma, marginal zone lymphoma and post-transplant lymphoproliferative disorder
(PTLD).;
Codes from synonyms : 19370; 128598; 128755; 128127; 127813; 128284; 128441; 127970;
Origin ID : C188467;
UMLS CUI : C1541445;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
